Loading...

TVGN TEVOGEN BIO HOLDINGS INC Capital Structure Changes 8-K Filing

TVGN

TVGN

TEVOGEN BIO HOLDINGS INC

(TVGN)

2024 8-K

Show Summary

Summary

Equity Offerings

Geographic Expansion

Management Changes

Management Changes

Grant Announcement

Stock Purchase Agreement

Entry into a Material Defin...

Loan Agreement with The Pat...

Amendment to Financial Stat...

Term Sheet Agreement

Appointment of Independent ...

Amendment to Financial Stat...

Financial Results Announcement

Amendment to Filing

Securities Purchase Agreement

Filing of Certificate of De...

Code of Business Conduct an...

Amendment to Previous Report

Merger of Equals

Shareholder Meeting

Merger Announcement

Amendment and Extension App...

Merger of Equals

Compliance with Nasdaq MVLS...

Merger Agreement

Merger Agreement

Purchase Agreement

Agreements and Delisting

Delisting Notice

Charter Amendment Approval

Conversion of Class B share...

Proxy Statement for EGM

External Links:

Tevogen Bio Holdings Inc. announced the sale of 600 shares of Series C Preferred Stock for $6 million, with two closings scheduled for August 30 and September 16, 2024, and a 7.5% annual cumulative dividend.

AI Assistant

TEVOGEN BIO HOLDINGS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.